Expression of CDX2 and villin in gastric cardiac intestinal metaplasia and the relation with gastric cardiac carcinogenesis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 1, 2012, Pages 247-250

  Xiao, Zhong Yue ^a   Ru, Yi ^a   Sun, Jiang Tao ^a   Gao, She Gan ^a   Wang, Yu Feng ^a   Wang, Li Dong ^b   Feng, Xiao Shan ^a  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Adenocarcinoma; CDX2; Gastric cardiac; Intestinal metaplasia; Protein expression; Villin

Indexed keywords

ACTIN BINDING PROTEIN; CDX2 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; VILLIN;

ADULT; AGED; ARTICLE; CARDIA; CHINA; FEMALE; GASTRITIS; HUMAN; INTESTINE MUCOSA; LYMPH NODE METASTASIS; MALE; METABOLISM; METAPLASIA; MIDDLE AGED; PATHOLOGY; PRECANCER; PROGNOSIS; STOMACH MUCOSA; STOMACH TUMOR;

ADULT; AGED; CARDIA; CHINA; FEMALE; GASTRIC MUCOSA; GASTRITIS; HOMEODOMAIN PROTEINS; HUMANS; INTESTINAL MUCOSA; LYMPHATIC METASTASIS; MALE; METAPLASIA; MICROFILAMENT PROTEINS; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 84864876004     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.1.247     Document Type: Article

References (26)

1. Athman R, Louvard D, Robine S (2002). The epithelial cell cytoskeleton and intracellular trafficking. III. How is villin involved in the actin cytoskeleton dynamics in intestinal cells? Am J Physiol Gastrointest Liver Physiol, 283, G496-502.
2. Blot WJ, Devesa SS, Kneller RW, et al (1991). Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA, 265, 1287-9.
3. Botterweck AA, Schouten LJ, Volovics A, et al (2000). Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol, 29, 645-54.
4. Dudouet B, Robine S, Huet C, et al (1987). Changes in villin synthesis and subcellular distribution during intestinal differentiation of HT29-18 clones. J Cell Biol, 105, 359-69.
5. Eda A, Osawa H, Satoh K, et al (2003). Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa. J Gastroenterol, 38, 14-22.
6. Eda A, Osawa H, Yanaka I, et al (2002). Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia. J Gastroenterol, 37, 94-100.
7. Fitzgerald RC, Omary MB, Triadafilopoulos G (1997). Acid modulation of HT29 cell growth and differentiation. An in vitro model for Barrett's esophagus. J Cell Sci, 110, 663-71.
8. Gao SG, Wang LD, Fan ZM, et al (2005). Histochemical studies on intestinal metaplasia adjacent to gastric cardia adenocarcinoma in subjects at high-incidence area in Henan, north China. World J Gastroenterol, 11, 4634-7.
9. Guo RJ, Suh ER, Lynch JP (2004). The role of Cdx proteins in intestinal development and cancer. Cancer Biol Ther, 3, 593-601.
10. Kerkhof M, Bax DA, Moons LM, et al (2006). Does CDX2 expression predict Barrett's metaplasia in oesophageal columnar epithelium without goblet cells? Aliment Pharmacol Ther, 24, 1613-21.
11. McColl KE (2006). Cancer of the gastric cardia. Best Pract Res Clin Gastroenterol, 20, 687-96.
12. Mesquita P, Jonckheere N, Almeida R, et al (2003). Human MUC2 mucin gene is transcriptionally regulated by Cdx homeodomain proteins in gastrointestinal carcinoma cell lines. J Biol Chem, 278, 51549-56.
13. Mutoh H, Sakurai S, Satoh K, et al (2004). Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice. Cancer Res, 64, 7740-7.
14. Niwa T, Ikehara Y, Nakanishi H, et al (2005). Mixed gastric- and intestinal-type metaplasia is formed by cells with dual intestinal and gastric differentiation. J Histochem Cytochem, 53, 75-85.
15. Odze RD (2005). Unraveling the mystery of the gastroesophageal junction: a pathologist's perspective. Am J Gastroenterol, 100, 1853-67.
16. Palli D, Bianchi S, Decarli A, et al (1992). A case-control study of cancers of the gastric cardia in Italy. Br J Cancer, 65, 263-6.
17. Regalado SP, Nambu Y, Iannettoni MD, et al (1998). Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas. Mol Carcinog, 22, 182-9.
18. Shi XY, Bhagwandeen B, Leong AS (2008). CDX2 and villin are useful markers of intestinal metaplasia in the diagnosis of Barrett esophagus. Am J Clin Pathol, 129, 571-7.
19. Siewert JR, Stein HJ, Feith M (2006). Adenocarcinoma of the esophago-gastric junction. Scand J Surg, 95, 260-9.
20. Silberg DG, Sullivan J, Kang E, et al (2002). Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology, 122, 689-96.
21. Silberg DG, Swain GP, Suh ER, et al (2000). Cdx1 and cdx2 expression during intestinal development. Gastroenterology, 119, 961-71.
22. Tsukamoto T, Inada K, Tanaka H, et al (2004). Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia. J Cancer Res Clin Oncol, 130, 135-45.
23. Villanacci V, Rossi E, Zambelli C, et al (2007). COX-2, CDX2, and CDC2 immunohistochemical assessment for dysplasia-carcinoma progression in Barrett's esophagus. Dig Liver Dis, 39, 305-11.
24. Weimann A, Rieger A, Zimmermann M, et al (2010). Comparison of six immunohistochemical markers for the histologic diagnosis of neoplasia in Barrett's esophagus. Virchows Arch, 457, 537-45.
25. Yamamichi N, Inada K, Furukawa C, et al (2009). Cdx2 and the Brm-type SWI/SNF complex cooperatively regulate villin expression in gastrointestinal cells. Exp Cell Res, 315, 1779-89.
26. Zhao CB, Zhou CJ, Guo JQ (2009) Expression of villin in precancerous lesions and gastric carcinoma and its clinical significance. J ShanDong University Med Sci, 47, 46-9